Resonance Energy Transfer for Assessing the Molecular Integrity of Proteins for Local Delivery

Biotechnology and Bioengineering

Volumn 85, Issue 4, 2004, Pages 406-412

  Wu, David ^a,c   Edelman, Elazer R ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Building 16 352 ^*  (United States)

Author keywords

FGF.2; Local delivery; Pharmacokinetics; Resonance energy transfer; Therapeutic angiogenesis

Indexed keywords

ENERGY TRANSFER; FLUORESCENCE; MOLECULAR DYNAMICS; PHARMACOKINETICS; RESONANCE; TISSUE;

RESONANCE ENERGY TRANSFER;

PROTEINS;

ANGIOGENIC FACTOR; FIBROBLAST GROWTH FACTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CATTLE; CONJUGATION; ENERGY TRANSFER; FLUORESCENCE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN TRANSPORT;

ANIMALS; CAROTID ARTERIES; CATTLE; CULTURE TECHNIQUES; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FIBROBLAST GROWTH FACTOR 2; FLUORESCENCE RESONANCE ENERGY TRANSFER; METABOLIC CLEARANCE RATE; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE DISTRIBUTION;

BOVINAE;

EID: 0442278168     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/bit.10902     Document Type: Article

References (41)

1. Bastiaens PI, Majoul IV, Verveer PJ, Soling HD, Jovin TM. 1996. Imaging the intracellular trafficking and state of the AB5 quaternary structure of cholera toxin. EMBO J 15(16):4246-4253.
2. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y. 2003. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9(5):604-613.
3. Chu L. 1998. Ligand transport through cellular matrices and the role of receptor-mediated trafficking. Cambridge: Massachusetts Institute of Technology.
4. Chu L, Wiley HS, Lauffenburger DA. 1996. Endocytic relay as a potential means for enhancing ligand transport through cellular tissue matrices: analysis and possible implications for drug delivery. Tissue Eng 2(1): 17-38.
5. Clegg RM. 1995. Fluorescence resonance energy transfer. Curr Opin Biotechnol 6(1):103-110.
6. Dinbergs ID, Brown L, Edelman ER. 1996. Cellular response to transforming growth factor-β1 and basic fibroblast growth factor depends on release kinetics and extracellular matrix interactions. J Biol Chem 271(47):29822-29829.
7. Dowd CJ, Cooney CL, Nugent MA. 1999. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J Biol Chem 274(8):5236-5244.
8. Flaumenhaft R, Moscatelli D, Rifkin DB. 1990. Heparin and heparan sulfate increase the radius of diffusion and action of basic fibroblast growth factor. J Cell Biol 111(4):1651-1659.
9. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, Manning WJ, Sellke FW, Simons M. 1994. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 94(2):623-630.
10. Healy AM, Herman IM. 1992. Preparation of fluorescent basic fibroblast growth factor: localization in living retinal microvascular endothelial cells. Exp Eye Res 55(5):663-669.
11. Hwang CW, Edelman ER. 2002. Arterial ultrastructure influences transport of locally delivered drugs. Circulation Res 90(7):826-832.
12. Hwang CW, Wu D, Edelman ER. 2001. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104(5): 600-605.
13. Jain RK. 1998. The next frontier of molecular medicine: delivery of therapeutics. Nat Med 4(6):655-657.
14. Koo EW, Gotlieb AI. 1989. Endothelial stimulation of intimal cell proliferation in a porcine aortic organ culture. Am J Pathol 134(3): 497-503.
15. Koo EW, Gotlieb AI. 1991. Neointimal formation in the porcine aortic organ culture. I. Cellular dynamics over 1 month. Lab Invest 64(6): 743-753.
16. Koo EW, Gotlieb AI. 1992. The use of organ cultures to study vessel wall pathobiology. Scanning Microsc 6(3):827-834; discussion 835.
17. Kornowski R, Fuchs S, Leon MB, Epstein SE. 2000. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation 101(4): 454-458.
18. Laham RJ, Hung D, Simons M. 1999a. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery. Clin Cardiol 22(1 Suppl 1):16-19.
19. Laham RJ, Rezaee M, Post M, Sellke FW, Braeckman RA, Hung D, Simons M. 1999b. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution. Drug Metab Dispos 27(7):821-826.
20. Lobb RR. 1988. Thrombin inactivates acidic fibroblast growth factor but not basic fibroblast growth factor. Biochemistry 27(7):2572-2578.
21. Mahoney MJ, Saltzman WM. 1999. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. Proc Natl Acad Sci USA 96(8):4536-4539.
22. McNeil PL, Muthukrishnan L, Warder E, D'Amore PA. 1989. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109(2):811-822.
23. Moscatelli D. 1992. Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix. J Biol Chem 267(36):25803-25809.
24. Ng T, Squire A, Hansra G, Bornancin F, Prevostel C, Hanby A, Harris W, Barnes D, Schmidt S, Mellor H, et al. 1999. Imaging protein kinase Cα activation in cells. Science 283(5410):2085-2089.
25. Nugent MA, Edelman ER. 1992. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity. Biochemistry 31(37):8876-8883.
26. Richardson TP, Peters MC, Ennett AB, Mooney DJ. 2001. Polymeric system for dual growth factor delivery. Nat Biotechnol 19(11): 1029-1034.
27. Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P. 1990. Growth factor control of extracellular proteolysis. Cell Differentiation Dev 32(3):313-318.
28. Rifkin DB, Moscatelli D, Flaumenhaft R, Sato Y, Saksela O, Tsuboi R. 1991. Mechanisms controlling the extracellular activity of basic fibroblast growth factor and transforming growth factor. Ann NY Acad Sci 614:250-258.
29. Rippley RK, Stokes CL. 1995. Effects of cellular pharmacology on drug distribution in tissues. Biophys J 69(3):825-839.
30. Rosengart TK, Johnson WV, Friesel R, Clark R, Maciag T. 1988. Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitro. Biochem Biophys Res Commun 152(1):432-440.
31. Saksela O, Moscatelli D, Sommer A, Rifkin DB. 1988. Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107(2):743-751.
32. Saltzman WM, Radomsky ML. 1991. Drugs released from polymers: diffusion and elimination in brain tissue. Chem Eng Sci 46(10): 2429-2444.
33. Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. 1998a. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results. Ann Thorac Surg 65(6):1540-1544.
34. Sellke FW, Tofukuji M, Laham RJ, Li J, Hariawala MD, Bunting S, Simons M. 1998b. Comparison of VEGF delivery techniques on collateral-dependent microvascular reactivity. Microvasc Res 55(2): 175-178.
35. Sperinde GV, Nugent MA. 2000. Mechanisms of fibroblast growth factor 2 intracellular processing: a kinetic analysis of the role of heparan sulfate proteoglycans. Biochemistry 39(13):3788-3796.
36. Uchiyama H, Hirano K, Kashiwasake-Jibu M, Taira K. 1996. Detection of undegraded oligonucleotides in vivo by fluorescence resonance energy transfer. Nuclease activities in living sea urchin eggs. J Biol Chem 271(1):380-384.
37. Vlodavsky I, Bar-Shavit R, Ishai-Michaeli R, Bashkin P, Fuks Z. 1991. Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism? Trends Biochem Sci 16(7):268-271.
38. Vlodavsky I, Folkman J, Sullivan R, Fridman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. 1987. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci USA 84(8):2292-2296.
39. Wan WK, Lovich MA, Hwang CW, Edelman ER. 1999. Measurement of drug distribution in vascular tissue using quantitative fluorescence microscopy. J Pharm Sci 88(8):822-829.
40. Wu P, Brand L. 1994. Resonance energy transfer: method and applications. Anal Biochem 218:1-13.
41. Yaron A, Carmel A, Katchalski-Katzir E. 1979. Intramolecularly quenched fluorogenic substrates for hydrolytic enzymes. Anal Biochem 95: 228-235.